Study of HS-10384 in Participants of Chinese Postmenopausal Women

NCT06122181 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Symptoms

Interventions

DRUG: HS-10384 tablets
DRUG: HS-10384-matched placebo tablets

Sponsor

Hansoh BioMedical R&D Company